DDR2 in cancer diagnosis, detection and treatment

Details for Australian Patent Application No. 2006235264 (hide)

Owner Novartis Vaccines and Diagnostics Inc. Sagres Discovery, Inc.

Inventors Moler, Edward; Rowe, Michael; Booher, Robert; Tse, Christin; Fanidi, Abdallah; Yu, Guoying; Xu, Xie

Agent FB Rice

Pub. Number AU-A-2006235264

PCT Pub. Number WO2006/110587

Priority 60/669,860 07.04.05 US

Filing date 7 April 2006

Wipo publication date 19 October 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110587 Priority application(s): WO2006/110587

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or report issued for this patent. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235266-Gammaretrovirus associated with cancer

2006235263-Identification of a new class of EPSP synthases